Participants were randomized to either daily minocycline hydrochloride (40 mg); doxycycline, the current standard of care; or ...

Low-dose doxycycline showed comparable efficacy with high-dose treatment in patients with lymphocytic scarring alopecia, with a lower rate of adverse events (AEs) and related discontinuations.